Literature DB >> 25110424

Pathophysiology of autism spectrum disorders: revisiting gastrointestinal involvement and immune imbalance.

Mohtashem Samsam1, Raheleh Ahangari1, Saleh A Naser1.   

Abstract

Autism spectrum disorders (ASD) comprise a group of neurodevelopmental abnormalities that begin in early childhood and are characterized by impairment of social communication and behavioral problems including restricted interests and repetitive behaviors. Several genes have been implicated in the pathogenesis of ASD, most of them are involved in neuronal synaptogenesis. A number of environmental factors and associated conditions such as gastrointestinal (GI) abnormalities and immune imbalance have been linked to the pathophysiology of ASD. According to the March 2012 report released by United States Centers for Disease Control and Prevention, the prevalence of ASD has sharply increased during the recent years and one out of 88 children suffers now from ASD symptoms. Although there is a strong genetic base for the disease, several associated factors could have a direct link to the pathogenesis of ASD or act as modifiers of the genes thus aggravating the initial problem. Many children suffering from ASD have GI problems such as abdominal pain, chronic diarrhea, constipation, vomiting, gastroesophageal reflux, and intestinal infections. A number of studies focusing on the intestinal mucosa, its permeability, abnormal gut development, leaky gut, and other GI problem raised many questions but studies were somehow inconclusive and an expert panel of American Academy of Pediatrics has strongly recommended further investigation in these areas. GI tract has a direct connection with the immune system and an imbalanced immune response is usually seen in ASD children. Maternal infection or autoimmune diseases have been suspected. Activation of the immune system during early development may have deleterious effect on various organs including the nervous system. In this review we revisited briefly the GI and immune system abnormalities and neuropeptide imbalance and their role in the pathophysiology of ASD and discussed some future research directions.

Entities:  

Keywords:  Autism spectrum disorders; Brain-derived neurotrophic factor; Crohn’s disease; Gastrointestinal abnormalities; Immune activation; Mycobacterium paratuberculosis; Neuropeptides

Mesh:

Year:  2014        PMID: 25110424      PMCID: PMC4123375          DOI: 10.3748/wjg.v20.i29.9942

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  114 in total

1.  Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation.

Authors:  K B Nelson; J K Grether; L A Croen; J M Dambrosia; B F Dickens; L L Jelliffe; R L Hansen; T M Phillips
Journal:  Ann Neurol       Date:  2001-05       Impact factor: 10.422

Review 2.  CNVs: harbingers of a rare variant revolution in psychiatric genetics.

Authors:  Dheeraj Malhotra; Jonathan Sebat
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

3.  Allelic expression analysis in the brain suggests a role for heterogeneous insults affecting epigenetic processes in autism spectrum disorders.

Authors:  Eyal Ben-David; Shahar Shohat; Sagiv Shifman
Journal:  Hum Mol Genet       Date:  2014-03-21       Impact factor: 6.150

Review 4.  Cholera: pathophysiology and emerging therapeutic targets.

Authors:  Chatchai Muanprasat; Varanuj Chatsudthipong
Journal:  Future Med Chem       Date:  2013-05       Impact factor: 3.808

Review 5.  Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting.

Authors:  Catalina Betancur
Journal:  Brain Res       Date:  2010-12-01       Impact factor: 3.252

Review 6.  Role for antibodies in altering behavior and movement.

Authors:  Jane E Libbey; Robert S Fujinami
Journal:  Autism Res       Date:  2010-08       Impact factor: 5.216

7.  Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine.

Authors:  T W Ho; L K Mannix; X Fan; C Assaid; C Furtek; C J Jones; C R Lines; A M Rapoport
Journal:  Neurology       Date:  2007-10-03       Impact factor: 9.910

8.  Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.

Authors:  Jes Olesen; Hans-Christoph Diener; Ingo W Husstedt; Peter J Goadsby; David Hall; Ulrich Meier; Stephane Pollentier; Lynna M Lesko
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

Review 9.  Autism spectrum disorders--a genetics review.

Authors:  Judith H Miles
Journal:  Genet Med       Date:  2011-04       Impact factor: 8.822

10.  Immunological characterization and transcription profiling of peripheral blood (PB) monocytes in children with autism spectrum disorders (ASD) and specific polysaccharide antibody deficiency (SPAD): case study.

Authors:  Harumi Jyonouchi; Lee Geng; Deanna L Streck; Gokce A Toruner
Journal:  J Neuroinflammation       Date:  2012-01-07       Impact factor: 8.322

View more
  27 in total

Review 1.  The Putative Role of Environmental Mercury in the Pathogenesis and Pathophysiology of Autism Spectrum Disorders and Subtypes.

Authors:  G Morris; B K Puri; R E Frye; M Maes
Journal:  Mol Neurobiol       Date:  2017-07-22       Impact factor: 5.590

Review 2.  Understanding Abnormal SMO-SHH Signaling in Autism Spectrum Disorder: Potential Drug Target and Therapeutic Goals.

Authors:  Saloni Rahi; Sidharth Mehan
Journal:  Cell Mol Neurobiol       Date:  2020-11-18       Impact factor: 5.046

Review 3.  Tetrahydrobiopterin and Its Multiple Roles in Neuropsychological Disorders.

Authors:  S Swathi Krishna; Samson K Wilson
Journal:  Neurochem Res       Date:  2022-02-10       Impact factor: 3.996

4.  Effects of auditory processing training on speech perception and brainstem plastisity in adolescents with autism spectrum disorders.

Authors:  Maryam Ramezani; Yones Lotfi; Abdollah Moossavi; Enayatollah Bakhshi
Journal:  Iran J Child Neurol       Date:  2021

Review 5.  Molecular Mechanisms of Aberrant Neuroplasticity in Autism Spectrum Disorders (Review).

Authors:  A A Anashkina; E I Erlykina
Journal:  Sovrem Tekhnologii Med       Date:  2021-02-28

6.  Reduced levels of plasma polyunsaturated fatty acids and serum carnitine in autistic children: relation to gastrointestinal manifestations.

Authors:  Gehan A Mostafa; Laila Y Al-Ayadhi
Journal:  Behav Brain Funct       Date:  2015-02-07       Impact factor: 3.759

Review 7.  Zinc in gut-brain interaction in autism and neurological disorders.

Authors:  Guillermo Vela; Peter Stark; Michael Socha; Ann Katrin Sauer; Simone Hagmeyer; Andreas M Grabrucker
Journal:  Neural Plast       Date:  2015-03-23       Impact factor: 3.599

Review 8.  Pediatric Traumatic Brain Injury and Autism: Elucidating Shared Mechanisms.

Authors:  Rahul Singh; Ryan C Turner; Linda Nguyen; Kartik Motwani; Michelle Swatek; Brandon P Lucke-Wold
Journal:  Behav Neurol       Date:  2016-12-15       Impact factor: 3.342

9.  Brief Report: Associations Between Self-injurious Behaviors and Abdominal Pain Among Individuals with ASD-Associated Disruptive Mutations.

Authors:  Evangeline C Kurtz-Nelson; See Wan Tham; Kaitlyn Ahlers; Daniel Cho; Arianne S Wallace; Evan E Eichler; Raphael A Bernier; Rachel K Earl
Journal:  J Autism Dev Disord       Date:  2020-11-11

Review 10.  Functional constipation in children: challenges and solutions.

Authors:  Elvira Ingrid Levy; Roel Lemmens; Yvan Vandenplas; Thierry Devreker
Journal:  Pediatric Health Med Ther       Date:  2017-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.